Navigation Links
Medicine quality in Philippines and region strengthened with Philippine FDA's accreditation
Date:7/12/2010

Rockville, Md., July 12, 2010 In an effort that will contribute to raising the quality of medicines in the Philippines and surrounding regions, the Laboratory Services Division (LSD) of the Philippine Food and Drug Administration (FDA) has attained the internationally recognized accreditation for testing and calibration laboratories, International Organization for Standardization/ International Electrotechnical Commission (ISO/IEC) 17025:2005. The FDA celebrates this achievement with its partners who assisted the laboratory in earning accreditation, including the U.S. Agency for International Development (USAID) and the Promoting the Quality of Medicines (PQM) Program, implemented by the U.S. Pharmacopeial Convention (USP).

"This is a milestone not only for the FDA, but for the people of the Philippines and the surrounding region," said Ms. Maria Lourdes C. Santiago, M.Sc. M.M., chief, LSD. We are demonstrating our commitment to public health by adherence to international standards for laboratory quality management. We greatly appreciate the timely support from USAID and PQM, which allowed us to anticipate and address issues prior to the formal accreditation process."

Added Ms. Nancy Tacandong, director, FDA, "I am thankful that USAID and PQM came at an opportune time and helped FDA in gaining accreditation. Filipino consumers and export industries stand to benefit from this achievement of the FDA."

PQM staff conducted training at the Philippines FDA on Good Laboratory Practices (GLP), Dissolution testing, and High Performance Liquid Chromatography (HPLC) analysis focused on the fixed-dose combination anti-tuberculosis (TB) medicine containing pyrazinamide, rifampicin, isoniazid and ethambutol. One of the main goals of this training was to equip analysts at both the main FDA site and the satellite laboratories in Cebu and Davao with the necessary analytical skills to determine the quality of anti-TB medicines in the Philippines.

The Philippine Accrediting Organization (PAO) awarded the FDA ISO/IEC accreditation for a wide scope of chemical and microbiological testing. This accreditation, recognized as the industry's top standard, validates that the FDA can provide valid and trustworthy data to the Department of Health, helping to ensure the quality of medicines to the country's citizens.

The PQM Program has provided technical assistance to the FDA since 2006 and established a medicines quality monitoring program for anti-TB medicines in the Philippines through funding from the USAID/Philippines Mission. According to Dr. Patrick Lukulay, director of the PQM Program, "I'm gratified that the LSD has earned accreditation from an international standards body. Through the PQM Program, USAID and USP are dedicated to helping national laboratories in developing countries improve public health through a science-based focus on medicines quality. To further this, USP headquarters will host visiting scientists from the LSD later this year to provide training on advanced quality lab techniques."

USAID is an independent agency that provides economic, development and humanitarian assistance around the world in support of the foreign policy goals of the United States. The PQM Program, implemented by USP, is a cooperative agreement with USAID that works to improve medicine quality in developing countries. The program focuses on the availability of high-quality medicines to treat life-threatening diseases including HIV/AIDS, malaria and tuberculosis. Lack of access to quality-assured medicines is a major public health threat throughout much of the world.


'/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. Is Frequency the Future of Medicine or an Ancient Mystery Revealed?
2. Impact of Azmacort Withdrawal Brought to Light in Medicine Community
3. Atlanta School of Sleep Medicine Offers Physician Board Review Course in October 2010
4. Breast milk transmits drugs and medicines to the baby
5. SEK100 million ($12.83 million) for Karolinska Institutets research into regenerative medicine
6. SNMs 2010 Annual Meeting reveals latest developments in molecular imaging and nuclear medicine
7. Sung-Cheng (Henry) Huang receives 2010 Benedict Cassen Prize for Research in Nuclear Medicine
8. Applied nuclear physics for biomedicine, nuclear security and basic science
9. US, Ukraine agree to share standards for quality of medicines
10. LocumTenens.com Announces Expansion into Emergency Medicine Staffing Physician Recruiting Firm Adds New Specialty to Its Service Lines
11. UIC to host Institute of Medicine Meeting on diabetes and obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... , ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows ... and civil society in 11 countries across the Middle East and South Asia to ... exchange of knowledge and ideas with the leading minds in their fields. , ...
(Date:6/23/2017)... ... 23, 2017 , ... PureLife Dental is pleased to announce that California Dental ... As part of the amalgam separator endorsement, all CDA members may purchase an ECO ... the retail value. This partnership between PureLife and CDA is especially timely as it ...
(Date:6/23/2017)... ... June 23, 2017 , ... American Farmer, will feature Chr. ... is slated to air fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on ... Danish pharmacist, founded Chr. Hansen in Denmark in 1874 after a groundbreaking discovery of ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... management, financial planning, and related services to families and business owners in and ... charity drive to benefit senior citizens in the area. , Meals on Wheels ...
(Date:6/23/2017)... ... , ... All-Star Insurance, a family managed agency that offers insurance management assistance ... the launch of a new charity drive to benefit women in the area diagnosed ... that an estimated 252, 710 new cases of invasive or high risk breast cancer ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... LAWRENCE, Mass. , June 2, 2017  NxStage ... advancing renal care, today announced new findings demonstrating positive ... NxStage ® System One™. The data will be ... 2017, in Madrid, Spain . ... Knowledge to Improve Home Dialysis Network in ...
(Date:5/29/2017)... TEL AVIV, Israel, May 29, 2017  Cellect Biotechnology ... of innovative technology which enables the functional selection of ... financial results for the first quarter ended March 31 ... pleased with our accomplishments in the first quarter of ... the first quarter, we announced the treatment of the ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
Breaking Medicine Technology: